Back

12-month post-trial follow-up of participants in the Australian arm of the second low-dose colchicine trial

29 August 2021 (07:24 - 07:33)
Organised by:
Congress Presentation Part of: Chronic coronary syndromes: pathophysiology, treatment, and prognosis Prevention ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Mark Nidorf

GenesisCare, Perth (Australia)

4 More presentations in this session

Presentation thumbnail
Impact of chronic coronary syndromes on cardiovascular hospitalization and mortality: the ESC-EORP CICD-LT registry
Doctor M. Kerneis (Paris, FR)
Abstract
Presentation thumbnail
Association of elevated lipoprotein(a) level and monocyte subsets with the severity of coronary atherosclerosis
Miss A. Filatova (Moscow, RU)
Abstract Slides Video
Presentation thumbnail
Sex-dependent impact of coronary microvascular dysfunction on long-term clinical outcomes in patients with no-obstructive coronary artery disease
Doctor T. Toya (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Detectable troponin below the 99th percentile predicts survival in patients with cardiovascular disease
Doctor L. Michel (Essen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic coronary syndromes: pathophysiology, treatment, and prognosis

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 07:24 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources